SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

14 Feb 2025 Evaluate
The company's total revenue for the quarter ended December 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 395.20 millions.The Net Profit of the company registered a slight decline of -0.31% to Rs. 129.72  millions from Rs. 130.12 millions.Operating profit surged to 191.07 millions from the corresponding previous quarter of 187.49 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 395.20 387.77 1.92 1130.63 1279.09 -11.61 1698.22 1483.85 14.45
Other Income 2.42 10.82 -77.63 10.85 32.54 -66.66 43.66 65.88 -33.73
PBIDT 191.07 187.49 1.91 538.92 611.51 -11.87 831.00 802.17 3.59
Interest 1.44 0.79 82.28 2.92 1.55 88.39 2.29 1.76 30.11
PBDT 189.63 186.70 1.57 536.00 609.96 -12.13 828.71 800.41 3.54
Depreciation 15.63 9.78 59.82 41.47 26.11 58.83 35.36 25.76 37.27
PBT 174.00 176.92 -1.65 494.53 583.85 -15.30 793.35 774.65 2.41
TAX 44.28 46.80 -5.38 126.77 151.09 -16.10 201.71 194.96 3.46
Deferred Tax -0.12 0.72 -116.67 0.49 2.79 -82.44 3.75 2.55 47.06
PAT 129.72 130.12 -0.31 367.76 432.76 -15.02 591.64 579.69 2.06
Equity 108.97 72.64 50.01 108.97 72.64 50.01 72.64 72.64 0.00
PBIDTM(%) 48.35 48.35 -0.01 47.67 47.81 -0.30 48.93 54.06 -9.48

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×